PembrolizumabmicvoPYX-201PYX-201-102HNSCC
…mary objective of dose escalation is to determine MTD and RP2D. Pembrolizumab (200 mg IV) will be given with micvo at escalating doses starti…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: PYX-201-102 ×
PYX-201-102
This drug is selected. Its supporting articles are shown below.